FDA clears Magnetom Spectra 3T MRI

The FDA has cleared the Magnetom Spectra 3T MRI system from Siemens Healthcare.

The MRI system features Tim (Total imaging matrix) 4G coil technology, as well Siemens’ MRI workflow technology Dot (Day optimizing throughput), which guides scanning strategy based on clinical indication and the patient's condition.

The scanner's array structure allows for high spatial and temporal resolution, according to Siemens. The company added that Magnetom Spectra's signal-to-noise ratio also supports image quality.

The system can be used for applications ranging from diagnosing damaged ankle cartilage to conducting dynamic abdominal examinations to performing functional brain imaging.
Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.